Literature DB >> 19133228

Clustering of disease-causing mutations on the domain-domain interfaces of ABCC6.

Krisztina Fülöp1, László Barna, Orsolya Symmons, Péter Závodszky, András Váradi.   

Abstract

Mutations in ABCC6 are responsible for pseudoxanthoma elasticum (PXE), a rare genetic disease affecting the elastic tissues of the body. ABCC6 encodes a 1503 amino acid long ABC transporter, ABCC6/MRP6. The functional link between the impaired activity of the protein and the disease is not known. We have built a homology model of this transporter, and analyzed the distribution of the known 119 missense PXE-associated mutations within the predicted structure. Significant clustering of the missense mutations has been found at complex domain-domain interfaces: at the transmission interface that involves four intracellular loops and the two ABC domains as well as at the ABC-ABC interacting surfaces. The mutations affecting these regions are 2.75 and 3.53-fold more frequent than the average mutational rate along the transporter protein sequence. These data provide a genetic proof of the importance of these domain-domain interactions in the ABCC6 transporter.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133228     DOI: 10.1016/j.bbrc.2008.12.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  ABCC6 as a target in pseudoxanthoma elasticum.

Authors:  András Váradi; Zalán Szabó; Viola Pomozi; Hugues de Boussac; Krisztina Fülöp; Tamás Arányi
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

2.  Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.

Authors:  Wael M Rabeh; Florian Bossard; Haijin Xu; Tsukasa Okiyoneda; Miklos Bagdany; Cory M Mulvihill; Kai Du; Salvatore di Bernardo; Yuhong Liu; Lars Konermann; Ariel Roldan; Gergely L Lukacs
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

3.  Nucleotide-free MalK drives the transition of the maltose transporter to the inward-facing conformation.

Authors:  Huan Bao; Franck Duong
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

4.  The nucleotide-binding domain 2 of the human transporter protein MRP6.

Authors:  Angela Ostuni; Rocchina Miglionico; Magnus Monné; Maria Antonietta Castiglione Morelli; Faustino Bisaccia
Journal:  J Bioenerg Biomembr       Date:  2011-07-12       Impact factor: 2.945

5.  Stabilization of Nucleotide Binding Domain Dimers Rescues ABCC6 Mutants Associated with Pseudoxanthoma Elasticum.

Authors:  Yanchao Ran; Patrick H Thibodeau
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

6.  Induced Structural Disorder as a Molecular Mechanism for Enzyme Dysfunction in Phosphoglucomutase 1 Deficiency.

Authors:  Kyle M Stiers; Bailee N Kain; Abigail C Graham; Lesa J Beamer
Journal:  J Mol Biol       Date:  2016-03-10       Impact factor: 5.469

7.  The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease.

Authors:  Gabriella Köblös; Hajnalka Andrikovics; Zoltán Prohászka; Attila Tordai; András Váradi; Tamás Arányi
Journal:  Genet Test Mol Biomarkers       Date:  2010-02

8.  Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms.

Authors:  Jouni Uitto; Qiaoli Li; Qiujie Jiang
Journal:  J Invest Dermatol       Date:  2009-12-24       Impact factor: 8.551

Review 9.  ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.

Authors:  Briana K Shimada; Viola Pomozi; Janna Zoll; Sheree Kuo; Ludovic Martin; Olivier Le Saux
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

10.  Mutagenic Analysis of the Putative ABCC6 Substrate-Binding Cavity Using a New Homology Model.

Authors:  Flora Szeri; Valentina Corradi; Fatemeh Niaziorimi; Sylvia Donnelly; Gwenaëlle Conseil; Susan P C Cole; D Peter Tieleman; Koen van de Wetering
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.